Virtuix Holdings Inc. — Form 8-K Summary
Business context and period: The filing reports outcomes of the company’s September 24, 2026 annual meeting and subsequent board and compensation actions. It was signed September 30, 2026. Virtuix is listed on Nasdaq under VTIX and identifies as an emerging growth company.
Financial and operating metrics
The filing does not report revenue, profit, cash flow, margins, debt, liquidity, guidance, or other operating results. It provides no financial comparison with a prior period.
Material developments
- CFO equity award: On September 29, the board approved a one-time discretionary grant of 100,000 restricted stock units to CFO Thomas McGinnis, described as recognition for exemplary service and not intended to affect the target value of his 2026 annual equity awards. Vesting is over four years: 25% after one year, then the remainder in 12 substantially equal quarterly installments, subject to continued service. Unvested units are forfeited upon termination; all units may be forfeited for termination for cause or breach of restrictive covenants. Change-in-control treatment is governed by the 2025 Omnibus Incentive Plan.
- Annual meeting: Holders approved the election of Ugo de Charette, John Cunningham, and Melissa Mohr as Class I directors through the 2029 annual meeting, and advisory ratification of EisnerAmper LLP as independent auditor for the fiscal year ending March 31, 2027. No other matters were submitted. The company reported 86,072,228 votes represented, equal to 78.31% of voting power. Class B shares carry 20 votes per share.
- Board roles: Following the meeting, Randolph C. Read was appointed Lead Independent Director. Melissa Mohr was appointed to the Audit Committee.
Outlook, risks, and unusual items
No business outlook or financial guidance is included. The notable compensation terms include continued-service vesting and forfeiture provisions; the filing refers to the incentive plan for change-in-control treatment but does not specify that treatment here.
Important facts for investors to verify
- Review the proxy statement and incentive plan for the RSU award’s full terms, potential dilution, and change-in-control provisions.
- Confirm the board and committee composition following the appointments.
- Review the fiscal 2027 filings for financial performance and auditor-related updates; this 8-K contains no financial results.